Filing Flows

Filing Flows › Entera Bio (ENTX) › Next earnings date

Entera Bio (ENTX) earnings on Nov 13, 2026: what to expect

Entera Bio (ENTX) is expected to report earnings on Nov 13, 2026 (estimated), in 5 days, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$0.07 (−$0.09 to −$0.05, 5 estimates), against −$0.07 a year ago. It beat the EPS estimate in 60% of the quarters on record; Filing Flows' model gives it a 78% chance of beating next time.

Report dateNov 13, 2026 (estimated)
Days to go5
EPS estimate−$0.07
Beat rate60%

The last report

Entera Bio reported revenue of $42K for the first quarter 2025, net loss $2.6M. How it makes money → · Every quarter →

Entera Bio: EPS against the estimate, last 4 reportsEntera Bio: EPS against the estimate, last 4 reportsEstimateReported−$0.09−$0.07Nov 25−$0.09−$0.06Mar 26−$0.08−$0.07May 26−$0.08−$0.14Aug 26
Latest (Aug 26): Estimate −$0.08, Reported −$0.14.

Entera Bio's latest quarter

Entera Bio, Q1 2025: revenue $42K, net loss $2.6M, operating cash flow −$1.4M. The chart follows the revenue to costs, profit and cash.

Questions

When does ENTX report earnings?

Entera Bio is expected to report on Nov 13, 2026 (estimated).

What are analysts expecting from Entera Bio?

EPS of −$0.07 for the quarter.

Does Entera Bio usually beat earnings?

It beat the consensus EPS estimate in 60% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.